Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で6789.73%の成長率を示しています。
成長中
同社は成長フェーズにあり、最新の年間収益はUSD 615.87Kに達しています。
高い利益成長
同社の純利益は業界をリードしており、最新の年間純利益はUSD 615.87Kです。
割高
同社の最新のPEは0.01で、過去3年間の水準と比較して高値圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は301.64K株で、前四半期比で8.76%減少しています。
バンガードが保有
スター投資家バンガードは本銘柄を192.00K株保有しています。